---
title: "百时美施贵宝的股价已经连续七个交易日下跌"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/285992594.md"
description: "百时美施贵宝（BMY）股票连续七个交易日下跌，周一下跌 0.9%，报 55.64 美元。该股在之前六个交易日中下跌了 3.5%，过去一个月下跌了 5%，尽管年初至今上涨了 4%。该公司最近公布的第一季度业绩好于预期"
datetime: "2026-05-11T20:31:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285992594.md)
  - [en](https://longbridge.com/en/news/285992594.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285992594.md)
---

# 百时美施贵宝的股价已经连续七个交易日下跌

Bristol-Myers Squibb (BMY) shares fell for seven straight sessions, as the stock was down 0.9% at $55.64 on Monday. The New Jersey-based pharma giant fell 3.5% in the preceding six sessions. The stock is down 5% over the past one month, while it has advanced 4% so far this year. Most recently, Bristol-Myers Squibb reported better-than-expected Q1 2...

### 相关股票

- [BMY.US](https://longbridge.com/zh-CN/quote/BMY.US.md)
- [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [PILL.US](https://longbridge.com/zh-CN/quote/PILL.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [RXL.US](https://longbridge.com/zh-CN/quote/RXL.US.md)
- [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [CELG.RT.US](https://longbridge.com/zh-CN/quote/CELG.RT.US.md)

## 相关资讯与研究

- [制药巨头集体拥抱 AI 智能体：百时美施贵宝向 3 万员工推广 Claude](https://longbridge.com/zh-CN/news/287074661.md)
- [百时美施贵宝向 3 万名员工全面开放 Anthropic 公司 Claude](https://longbridge.com/zh-CN/news/287085684.md)
- [强生重症肌无力治疗新药获国家药监局批准上市](https://longbridge.com/zh-CN/news/287196062.md)
- [Scholar Rock 将出席杰富瑞全球医疗保健大会，聚焦 SMA 新药 apitegromab 关键审批](https://longbridge.com/zh-CN/news/287069556.md)
- [CAR-T 迎接新时代](https://longbridge.com/zh-CN/news/286999381.md)